Clinical Trial Update: Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients [Phase 1]

View source ↗

Summary

This entry reports the completion of a Phase 1 trial evaluating immunotherapy in HLA-A2 positive patients with stage III/IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Immunotherapy (unspecified)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Melanoma | Phase 1 | Status: COMPLETED